How might Biofourmis refine its wearable biosensor technology to increase comfort and long-term adherence for patients?

Introduction

To refine Biofourmis' wearable biosensor technology for increased comfort and long-term adherence, we need to deeply understand our users, their pain points, and potential innovative solutions. I'll approach this challenge by first clarifying key aspects, then analyzing user segments and pain points, before proposing and evaluating solutions. Let's begin with some clarifying questions to ensure we're aligned on the context and objectives.

Step 1

Clarifying Questions

• Looking at Biofourmis' product positioning, I'm thinking this technology is primarily used for continuous health monitoring in chronic disease management. Could you confirm if this is the primary use case, or are there other significant applications we should consider?

Why it matters: Determines the scope of our improvement efforts and potential trade-offs. Expected answer: Primarily for chronic disease management, with some use in clinical trials. Impact on approach: Would focus on long-term comfort for daily wear vs. short-term precision for clinical settings.

• Considering the emphasis on long-term adherence, I'm curious about the current usage patterns. What's the average duration users wear the biosensor continuously, and what's our target for improvement?

Why it matters: Helps quantify the adherence challenge and set clear goals for our solutions. Expected answer: Current average is 14 days, aiming to increase to 30 days. Impact on approach: Would prioritize solutions that address fatigue and irritation over initial comfort.

• Given the focus on comfort, I'm wondering about the current form factor and placement of the biosensor. Can you share details on its size, weight, and typical wear location?

Why it matters: Informs potential physical design improvements and constraints. Expected answer: Current sensor is 5cm x 3cm, weighs 15g, typically worn on the upper arm. Impact on approach: Would explore alternative form factors or placement options if size is a major issue.

• Thinking about the competitive landscape, I'm curious how Biofourmis' adherence rates compare to other wearable health tech. Do we have data on where we stand in the market regarding long-term use?

Why it matters: Helps benchmark our performance and identify areas where we can differentiate. Expected answer: We're in the top quartile but trailing market leaders by about 15% in 30-day adherence. Impact on approach: Would focus on leap-frogging competitors with innovative comfort solutions.